DuPont de Nemours, Inc. (DD)
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company has a collaboration with Microsoft and NobleAI to expand access to advanced AI tools and resources, including machine learning that helps scientists and engineers innovate faster. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.
- Ticker
- DD
- Exchange
- NYSE
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Market cap
- $20.18B
- 52-week range
- $111.15 - $159.48
Valuation
- Share price
- $150.23 (close of Nov 18, 2026)
- P/E (TTM)
- 67.07x
- Price to book
- 1.47x
- Price to free cash flow
- 25.44x
- Enterprise value
- $21.62B
- Book value per share
- $101.94
Price performance
| Period | Change |
|---|---|
| 1 day | +0.06% |
| 5 days | -3.46% |
| 1 month | +15.16% |
| 3 months | +8.23% |
| 6 months | +2.95% |
| Year to date | +24.57% |
| 1 year | +29.40% |
| 3 years | +68.04% |
| 5 years | +50.50% |
| 10 years | +57.97% |
| All time | +1,545.25% |
Short interest
- As of
- Oct 30, 2026
- Short % of float
- 3.33%
- Shares short
- 3.87M
- Days to cover
- 4.64
- Change since prior report
- -17.39%
- Source
- FINRA consolidated short interest
Members of Congress who disclosed DD trades
Gilbert Ray Cisneros · Jefferson Shreve · Robert Bresnahan
Super investors holding DD
Ken Griffin (Citadel) · Hillman Capital (Hillman Capital Management, Inc) · Lee Ainslie (Maverick Capital LTD) · Dodge & Cox (Dodge & Cox Funds) · Ray Dalio (Bridgewater Associates)
Profitability and growth
- Return on equity
- -5.52%
- Return on invested capital
- 2.38%*
- Return on assets
- -3.61%
- Return on capital employed
- 2.66%*
- Gross margin
- 34.50%
- Net margin
- -11.37%
- EBITDA margin
- 4.13%
- Revenue growth
- 1.93%
- Net income growth
- -210.81%
- Free cash flow growth
- -52.71%
* Estimated EBIT: pre-tax income + net interest. This company reports no operating income line.
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 3.93%
- Current ratio
- 2.36x
- Net debt to EBITDA
- 2.69x
Latest reported year
- Period end
- Dec 31, 2025
- Fiscal year
- 2025
- Revenue
- $6.85B
- Cost of revenue
- $4.49B
- Gross profit
- $2.36B
- EBITDA
- $283.00M
- Net income
- -$779.00M
- Earnings per share
- $-5.61
- Research and development
- $193.00M
- Interest expense
- $313.00M
- Shares outstanding
- 139.17M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|---|---|---|---|
| 2025-12-31 | $6.85B | $2.36B | -$779.00M | -$5.61 |
| 2024-12-31 | $6.72B | $2.22B | $703.00M | $5.04 |
| 2023-12-31 | $6.61B | $2.17B | $423.00M | $2.82 |
| 2022-12-31 | $13.02B | $4.62B | $5.87B | $35.31 |
| 2021-12-31 | $12.57B | $4.59B | $6.47B | $35.76 |
| 2020-12-31 | $11.13B | $4.07B | -$2.95B | -$12.03 |
| 2019-12-31 | $15.44B | $5.41B | $498.00M | $2.01 |
| 2018-12-31 | $22.59B | - | $3.85B | $14.97 |
| 2017-12-31 | $11.67B | - | $1.16B | $6.54 |
| 2016-12-31 | $48.16B | - | $4.32B | $32.13 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|---|---|---|---|
| 2025-12-31 | 34.50% | -11.37% | -5.52% | 2.38%* |
| 2024-12-31 | 33.04% | 10.46% | 2.95% | 0.87%* |
| 2023-12-31 | 32.84% | 6.40% | 1.71% | 0.36%* |
| 2022-12-31 | 35.45% | 45.08% | 21.72% | 4.43%* |
| 2021-12-31 | 36.57% | 51.46% | 23.91% | 4.53%* |
| 2020-12-31 | 36.53% | -26.52% | -7.55% | -1.07%* |
| 2019-12-31 | 35.05% | 3.23% | 1.20% | 1.78%* |
| 2018-12-31 | - | 17.02% | 4.01% | 0.55%* |
| 2017-12-31 | - | 9.93% | 1.14% | -0.56%* |
| 2016-12-31 | - | 8.97% | 15.85% | 10.82%* |
* Estimated EBIT: pre-tax income + net interest. This company reports no operating income line.
Cash and debt by year
| Period end | Cash | Debt |
|---|---|---|
| 2025-12-31 | $715.00M | $3.13B |
| 2024-12-31 | $1.79B | $5.32B |
| 2023-12-31 | $2.39B | $7.86B |
| 2022-12-31 | $3.66B | $8.14B |
| 2021-12-31 | $1.97B | $10.63B |
| 2020-12-31 | $2.54B | $15.61B |
| 2019-12-31 | $1.54B | -$15.62B |
| 2018-12-31 | $8.58B | -$12.63B |
| 2017-12-31 | $14.39B | $32.12B |
| 2016-12-31 | $6.61B | $21.09B |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|---|---|
| 2025-12-31 | $227.00M | $38.00M |
| 2024-12-31 | $480.00M | $56.00M |
| 2023-12-31 | $543.00M | $57.00M |
| 2022-12-31 | -$74.00M | $75.00M |
| 2021-12-31 | $1.49B | $67.00M |
| 2020-12-31 | $2.90B | $93.00M |
| 2019-12-31 | -$1.06B | $87.00M |
| 2018-12-31 | $3.49B | $92.00M |
| 2017-12-31 | -$1.32B | $19.00M |
| 2016-12-31 | -$6.76B | $261.00M |
Dividend history
- Most recent payment
- Aug 31, 2026
- Paid in the last twelve months, split-adjusted
- $2.40
| Payment date | Dividend per share |
|---|---|
| 2026-08-31 | $0.60 |
| 2026-05-15 | $0.20 |
| 2026-03-02 | $0.20 |
| 2025-11-28 | $0.20 |
| 2025-08-29 | $0.41 |
| 2025-05-30 | $0.41 |
| 2025-03-03 | $0.41 |
| 2024-11-29 | $0.38 |
Investor relations
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-11-03 | Sep 2026 | $1.86 |
| 2026-08-04 | Jun 2026 | $1.76 |
| 2026-05-05 | Mar 2026 | $0.48 |
| 2026-02-10 | Dec 2025 | $0.43 |
| 2025-11-06 | Sep 2025 | $1.04 |
| 2025-08-05 | Jun 2025 | $1.06 |
| 2025-05-02 | Mar 2025 | $0.95 |
| 2025-02-11 | Dec 2024 | $0.98 |
Filings and sources
- Company website
- dupont.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Albemarle Corp (ALB) · LyondellBasell Industries N.V. (LYB) · Solstice Advanced Materials Inc. (SOLS) · International Flavors & Fragrances Inc (IFF) · Eastman Chemical Co (EMN) · PPG Industries Inc (PPG) · Air Products & Chemicals, Inc. (APD) · Ecolab Inc. (ECL)
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades